This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Master Pharm Beheer
Beheer criteriumcontroles 1/4
Belangrijke informatie
Jacek Franasik
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | 19.9yrs |
Eigendom CEO | 71.8% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | 7.2yrs |
Recente managementupdates
Recent updates
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)
Feb 05Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes
Dec 13A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)
May 25Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends
Mar 30Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease
Feb 04Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?
Jan 08Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital
Dec 18Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 27CEO
Jacek Franasik
19.9yrs
Tenure
zł859,623
Compensatie
Mr. Jacek Franasik has been President of Management Board and Partner of Master Pharm SA since October 25, 2002. Mr. Franasik served as Chief Commercial Officer at Agropharm S.A. from 1999 to 2003. He has...
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Independent Chairman of Supervisory Board | 7.2yrs | zł25.39k | geen gegevens | |
Independent Vice Chairman of Supervisory Board | 7.2yrs | zł12.70k | geen gegevens | |
Member of Supervisory Board | 7yrs | zł12.70k | geen gegevens |
7.2yrs
Gemiddelde duur
Ervaren bestuur: MPH's board of directors are considered experienced (7.2 years average tenure).